Acasă › Cancer endometrial › Oregon › Portland
Studii clinice pentru Cancer endometrial în Portland, OR
24 studii pentru Cancer endometrial caută participanți în și în jurul orașului Portland (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
În curs de recrutareFaza 3
- Legacy Good Samaritan Hospital and Medical Center, Portland
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
În curs de recrutareFaza 2
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Oregon Health and Science University, Portland
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
În curs de recrutareFaza 1/2
- Research Site, Portland
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
În curs de recrutareFaza 1/2
- Oregon Health & Science University (OHSU), Portland
A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
În curs de recrutareFaza 1
- Site 02, Portland
Study of AVZO-021 in Patients With Advanced Solid Tumors
În curs de recrutareFaza 1/2
- Avenzo Therapeutics Recruiting Site, Portland
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
În curs de recrutareFaza 2
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
În curs de recrutareFaza 1
- Research Site, Portland
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
În curs de recrutareFaza 2
- Providence Portland Medical Centre, Portland
- Providence Saint Vincent Medical Center, Portland
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
În curs de recrutareFaza 1
- Providence Portland Medical Center, Portland
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
În curs de recrutareFaza 3
- USOR - NW Cancer Specs P.C., Portland
A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors
În curs de recrutareFaza 1
- Providence Cancer Institute of Oregon, Portland
FOG-001 in Locally Advanced or Metastatic Solid Tumors
În curs de recrutareFaza 1/2
- Oregon Health and Science University, Portland
A Study of MGC026 in Participants With Advanced Solid Tumors
În curs de recrutareFaza 1
- Providence Cancer Institute, Portland
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
În curs de recrutareFaza 1/2
- Compass Oncology - Rose Quarter, Portland
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
În curs de recrutareFaza 1/2
- Oregon Health & Science University, Portland
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
În curs de recrutareFaza 3
- Research Site, Portland
Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
În curs de recrutareFaza 1
- Investigative Site #121, Portland
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
În curs de recrutareFaza 1/2
- Providence Cancer Institute Franz Clinic, Portland
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
- Oregon Health Sciences University, Portland
Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
În curs de recrutareFaza 2
- Northwest Cancer Specialists, P.C., Portland
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
În curs de recrutareStudiu observațional
- Massive Bio SYNERGY-AI site, Portland
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
În curs de recrutareFaza 1/2
- Oregon Health & Science University, Portland
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
În curs de recrutareFaza 2/3
- Northwest Cancer Specialists, Portland
Studii pentru Cancer endometrial în alte orașe
- Houston, TX68 studii
- New York City, NY52 studii
- Boston, MA50 studii
- Arlington, VA39 studii
- Nashville, TN38 studii
- Los Angeles, CA34 studii
- St. Louis, MO29 studii
- Philadelphia, PA28 studii
- San Antonio, TX27 studii
- Columbus, OH25 studii
- Oklahoma City, OK25 studii
- Chicago, IL25 studii
Alte studii în Portland
- Cancer pulmonar cu celule non-pătrate46 studii
- Cancer (toate tipurile)34 studii
- Cancer de sân33 studii
- Cancer de prostată33 studii
- Cancer metastatic29 studii
- Cancer colorectal28 studii
- Cancer ovarian27 studii
- Cancer pulmonar26 studii
- Leucemie mieloasă acută25 studii
- Carcinom cu celule scuamoase de cap și gât19 studii
- Cancer pancreatic19 studii
- Insuficiență cardiacă17 studii
Sursă: ClinicalTrials.gov, date preluate la 6 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.